Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:22-28
doi: 10.1161/hy1201.097300
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattori, Y.
Right arrow Articles by Kasai, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hattori, Y.
Right arrow Articles by Kasai, K.
Related Collections
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Growth factors/cytokines
Right arrow Smooth muscle proliferation and differentiation

(Hypertension. 2002;39:22.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Vascular Smooth Muscle Cell Activation by Glycated Albumin (Amadori Adducts)

Yoshiyuki Hattori; Manabu Suzuki; Sachiko Hattori; Kikuo Kasai

From the Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi, Japan

Correspondence to Dr Yoshiyuki Hattori, Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan. E-mail yhattori{at}dokkyomed.ac.jp

Nonenzymatic glycation is increased in diabetes. The role of advanced glycation end products has been implicated in many of the complications of diabetes, whereas the effects of early-glycation Amadori-modified proteins on vascular cells alone are poorly defined. In the present study, we show that glycated serum albumin (GSA) induces a parallel activation of the redox-responsive transcription factors (nuclear factor {kappa}B) and AP-1 and increases activity of mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase (ERK), and p38 MAPK in vascular smooth muscle cells (VSMCs). GSA increased expression of early response genes, c-fos and c-jun, and inflammatory genes, monocyte chemoattractant peptide (MCP-1), and interleukin (IL)-6. These effects were comparable to bacterial lipopolysaccharide, tumor necrosis factor-{alpha}a, (TNF-{alpha}a), IL-1{alpha}b, angiotensin II, epidermal growth factor, and the phorbol ester PMA. One of signaling pathways by which GSA activates VSMCs appears to be via nuclear factor {kappa}B activation, leading to induction of MCP-1 and IL-6 gene expression, comparable to the effects of lipopolysaccharide, TNF-{alpha}a, and IL-1{alpha}b. Another signaling cascade by which GSA activates VSMCs is the ERK->c-Fos->AP-1 pathway, which may lead to stimulation of cell proliferation and migration. These effects are comparable to the effects of angiotensin II, epidermal growth factor, and PMA. Incubation of VSMCs with the antioxidant N-acetylcysteine suppressed GSA-elicited mRNA induction of MCP-1 and IL-6. Inhibition of p38 MAPK but not ERK caused attenuation of MCP-1 and IL-6 mRNA induction. Finally, GSA caused a significant stimulation of VSMC growth and migration. These findings suggest that GSA may play a role in diabetic atherogenesis by activating VSMCs, leading to induction of inflammatory mediators in the vessel wall, as well as proliferation and migration of VSMCs.


Key Words: glycation • albumin • inflammation • proliferation • migration • muscle, smooth, vascular




This article has been cited by other articles:


Home page
Eur Respir JHome page
P. Faure, R. Tamisier, J-P. Baguet, A. Favier, S. Halimi, P. Levy, and J-L. Pepin
Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome
Eur. Respir. J., May 1, 2008; 31(5): 1046 - 1053.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Hattori, S. Hattori, K. Akimoto, T. Nishikimi, K. Suzuki, H. Matsuoka, and K. Kasai
Globular Adiponectin Activates Nuclear Factor-{kappa}B and Activating Protein-1 and Enhances Angiotensin II-Induced Proliferation in Cardiac Fibroblasts
Diabetes, March 1, 2007; 56(3): 804 - 808.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Hattori, K. Suzuki, S. Hattori, and K. Kasai
Metformin Inhibits Cytokine-Induced Nuclear Factor {kappa}B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells
Hypertension, June 1, 2006; 47(6): 1183 - 1188.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Reddy, S.-L. Li, S. Sahar, Y.-S. Kim, Z.-G. Xu, L. Lanting, and R. Natarajan
Key Role of Src Kinase in S100B-induced Activation of the Receptor for Advanced Glycation End Products in Vascular Smooth Muscle Cells
J. Biol. Chem., May 12, 2006; 281(19): 13685 - 13693.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Zhang, A. L. Kho, N. Anilkumar, R. Chibber, P. J. Pagano, A. M. Shah, and A. C. Cave
Glycated Proteins Stimulate Reactive Oxygen Species Production in Cardiac Myocytes: Involvement of Nox2 (gp91phox)-Containing NADPH Oxidase
Circulation, March 7, 2006; 113(9): 1235 - 1243.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Igata, H. Motoshima, K. Tsuruzoe, K. Kojima, T. Matsumura, T. Kondo, T. Taguchi, K. Nakamaru, M. Yano, D. Kukidome, et al.
Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression
Circ. Res., October 14, 2005; 97(8): 837 - 844.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Jaleel, P. Halvatsiotis, B. Williamson, P. Juhasz, S. Martin, and K. S. Nair
Identification of Amadori-Modified Plasma Proteins in Type 2 Diabetes and the Effect of Short-Term Intensive Insulin Treatment
Diabetes Care, March 1, 2005; 28(3): 645 - 652.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Miele, A. Riboulet, M. A. Maitan, F. Oriente, C. Romano, P. Formisano, J. Giudicelli, F. Beguinot, and E. Van Obberghen
Human Glycated Albumin Affects Glucose Metabolism in L6 Skeletal Muscle Cells by Impairing Insulin-induced Insulin Receptor Substrate (IRS) Signaling through a Protein Kinase C{alpha}-mediated Mechanism
J. Biol. Chem., November 28, 2003; 278(48): 47376 - 47387.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Hattori, M. Matsumura, and K. Kasai
Vascular smooth muscle cell activation by C-reactive protein
Cardiovasc Res, April 1, 2003; 58(1): 186 - 195.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Schiekofer, M. Andrassy, J. Chen, G. Rudofsky, J. Schneider, T. Wendt, N. Stefan, P. Humpert, A. Fritsche, M. Stumvoll, et al.
Acute Hyperglycemia Causes Intracellular Formation of CML and Activation of ras, p42/44 MAPK, and Nuclear Factor {kappa}B in PBMCs
Diabetes, March 1, 2003; 52(3): 621 - 633.
[Abstract] [Full Text] [PDF]